

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid transmembrane transport (GO:1902001) | 4.39464698 |
| 2 | carnitine shuttle (GO:0006853) | 4.34442538 |
| 3 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.00084637 |
| 4 | glomerular basement membrane development (GO:0032836) | 3.92405416 |
| 5 | fatty acid beta-oxidation (GO:0006635) | 3.90392523 |
| 6 | regulation of sequestering of triglyceride (GO:0010889) | 3.90032590 |
| 7 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.85845573 |
| 8 | lysine metabolic process (GO:0006553) | 3.84623167 |
| 9 | lysine catabolic process (GO:0006554) | 3.84623167 |
| 10 | positive regulation of fatty acid oxidation (GO:0046321) | 3.79554748 |
| 11 | glomerular visceral epithelial cell development (GO:0072015) | 3.69125218 |
| 12 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66284267 |
| 13 | regulation of fatty acid oxidation (GO:0046320) | 3.55410976 |
| 14 | valine metabolic process (GO:0006573) | 3.52482192 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 3.50556345 |
| 16 | fatty acid oxidation (GO:0019395) | 3.49177442 |
| 17 | biotin metabolic process (GO:0006768) | 3.45653750 |
| 18 | cardiac myofibril assembly (GO:0055003) | 3.43711701 |
| 19 | lipid oxidation (GO:0034440) | 3.40735188 |
| 20 | low-density lipoprotein particle clearance (GO:0034383) | 3.40345018 |
| 21 | cell migration involved in heart development (GO:0060973) | 3.39783901 |
| 22 | carnitine transmembrane transport (GO:1902603) | 3.36945783 |
| 23 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.34116064 |
| 24 | fatty acid catabolic process (GO:0009062) | 3.33412978 |
| 25 | extracellular matrix assembly (GO:0085029) | 3.31607902 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 3.30689736 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.30689736 |
| 28 | plasma membrane repair (GO:0001778) | 3.28829393 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.27656866 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 3.27580771 |
| 31 | carnitine transport (GO:0015879) | 3.25737887 |
| 32 | amino-acid betaine transport (GO:0015838) | 3.25737887 |
| 33 | acetyl-CoA metabolic process (GO:0006084) | 3.23799689 |
| 34 | glomerular epithelial cell development (GO:0072310) | 3.23074152 |
| 35 | L-phenylalanine catabolic process (GO:0006559) | 3.22160569 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.22160569 |
| 37 | sarcomere organization (GO:0045214) | 3.21254962 |
| 38 | positive regulation of protein kinase C signaling (GO:0090037) | 3.19082468 |
| 39 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.18689761 |
| 40 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.17794547 |
| 41 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.15674001 |
| 42 | glyoxylate metabolic process (GO:0046487) | 3.14837686 |
| 43 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.13260468 |
| 44 | protein heterotrimerization (GO:0070208) | 3.12935410 |
| 45 | extracellular fibril organization (GO:0043206) | 3.09688714 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.05316844 |
| 47 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.04341398 |
| 48 | tricarboxylic acid cycle (GO:0006099) | 3.03979914 |
| 49 | surfactant homeostasis (GO:0043129) | 3.02371556 |
| 50 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.01404975 |
| 51 | endothelial cell chemotaxis (GO:0035767) | 3.00868427 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 2.98663708 |
| 53 | lymph vessel development (GO:0001945) | 2.98582978 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 2.98411844 |
| 55 | semaphorin-plexin signaling pathway (GO:0071526) | 2.96634604 |
| 56 | epoxygenase P450 pathway (GO:0019373) | 2.95378734 |
| 57 | monocarboxylic acid catabolic process (GO:0072329) | 2.94550940 |
| 58 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.93860910 |
| 59 | tricarboxylic acid metabolic process (GO:0072350) | 2.93153601 |
| 60 | regulation of protein activation cascade (GO:2000257) | 2.90170485 |
| 61 | aspartate family amino acid catabolic process (GO:0009068) | 2.89262738 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 2.88982867 |
| 63 | branched-chain amino acid metabolic process (GO:0009081) | 2.88181869 |
| 64 | regulation of complement activation (GO:0030449) | 2.86857473 |
| 65 | short-chain fatty acid metabolic process (GO:0046459) | 2.86746559 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 2.85671803 |
| 67 | basement membrane organization (GO:0071711) | 2.85387801 |
| 68 | myofibril assembly (GO:0030239) | 2.85340094 |
| 69 | heart trabecula formation (GO:0060347) | 2.85071640 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 2.84969502 |
| 71 | positive regulation of lipid catabolic process (GO:0050996) | 2.83609570 |
| 72 | regulation of p38MAPK cascade (GO:1900744) | 2.83335576 |
| 73 | atrioventricular valve morphogenesis (GO:0003181) | 2.82609710 |
| 74 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82589740 |
| 75 | protein carboxylation (GO:0018214) | 2.82589740 |
| 76 | barbed-end actin filament capping (GO:0051016) | 2.82539112 |
| 77 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.82514608 |
| 78 | triglyceride homeostasis (GO:0070328) | 2.81027139 |
| 79 | acylglycerol homeostasis (GO:0055090) | 2.81027139 |
| 80 | carnitine metabolic process (GO:0009437) | 2.80956998 |
| 81 | positive regulation of p38MAPK cascade (GO:1900745) | 2.79664851 |
| 82 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.79321915 |
| 83 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.76501638 |
| 84 | cell volume homeostasis (GO:0006884) | 2.75959513 |
| 85 | oxaloacetate metabolic process (GO:0006107) | 2.72779847 |
| 86 | positive regulation of receptor recycling (GO:0001921) | 2.71449308 |
| 87 | adherens junction assembly (GO:0034333) | 2.70529936 |
| 88 | kynurenine metabolic process (GO:0070189) | 2.69487756 |
| 89 | renal filtration (GO:0097205) | 2.68077933 |
| 90 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.67860535 |
| 91 | lymphangiogenesis (GO:0001946) | 2.67669748 |
| 92 | fibril organization (GO:0097435) | 2.67442385 |
| 93 | ethanol oxidation (GO:0006069) | 2.67092706 |
| 94 | quaternary ammonium group transport (GO:0015697) | 2.66807549 |
| 95 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.66435369 |
| 96 | venous blood vessel morphogenesis (GO:0048845) | 2.65172171 |
| 97 | cGMP-mediated signaling (GO:0019934) | 2.65158776 |
| 98 | homocysteine metabolic process (GO:0050667) | 2.64758676 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 2.64398306 |
| 100 | aromatic amino acid family catabolic process (GO:0009074) | 2.63822619 |
| 101 | blood vessel endothelial cell migration (GO:0043534) | 2.63133939 |
| 102 | triglyceride catabolic process (GO:0019433) | 2.62848060 |
| 103 | negative regulation of fatty acid transport (GO:2000192) | 2.62310556 |
| 104 | cell-substrate junction assembly (GO:0007044) | 2.61733575 |
| 105 | cellular response to epinephrine stimulus (GO:0071872) | 2.60868904 |
| 106 | endocrine hormone secretion (GO:0060986) | 2.60779042 |
| 107 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.59561370 |
| 108 | regulation of cholesterol storage (GO:0010885) | 2.59139327 |
| 109 | 4-hydroxyproline metabolic process (GO:0019471) | 2.58562258 |
| 110 | NADH metabolic process (GO:0006734) | 2.56771180 |
| 111 | apoptotic cell clearance (GO:0043277) | 2.56187761 |
| 112 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.56141385 |
| 113 | endothelium development (GO:0003158) | 2.55939197 |
| 114 | cell-substrate adherens junction assembly (GO:0007045) | 2.55542218 |
| 115 | focal adhesion assembly (GO:0048041) | 2.55542218 |
| 116 | glomerular filtration (GO:0003094) | 2.54642213 |
| 117 | transcytosis (GO:0045056) | 2.54228673 |
| 118 | dermatan sulfate metabolic process (GO:0030205) | 2.54131417 |
| 119 | regulation of plasminogen activation (GO:0010755) | 2.53405476 |
| 120 | phospholipid homeostasis (GO:0055091) | 2.53347283 |
| 121 | chondroitin sulfate catabolic process (GO:0030207) | 2.52970505 |
| 122 | neutral lipid catabolic process (GO:0046461) | 2.52962633 |
| 123 | acylglycerol catabolic process (GO:0046464) | 2.52962633 |
| 124 | endothelial cell morphogenesis (GO:0001886) | 2.52911252 |
| 125 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.52104382 |
| 126 | cysteine metabolic process (GO:0006534) | 2.51128916 |
| 127 | cellular ketone body metabolic process (GO:0046950) | 2.50912137 |
| 128 | mannose metabolic process (GO:0006013) | 2.46788593 |
| 129 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.46483436 |
| 130 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.46483436 |
| 131 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.45379720 |
| 132 | cAMP biosynthetic process (GO:0006171) | 2.44603224 |
| 133 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.42270079 |
| 134 | collagen fibril organization (GO:0030199) | 2.41973849 |
| 135 | regulation of apoptotic cell clearance (GO:2000425) | 2.41958436 |
| 136 | activation of protein kinase A activity (GO:0034199) | 2.40416737 |
| 137 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.37905409 |
| 138 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.36052784 |
| 139 | metanephric nephron epithelium development (GO:0072243) | 2.36022626 |
| 140 | stress fiber assembly (GO:0043149) | 2.32685258 |
| 141 | adhesion of symbiont to host (GO:0044406) | 2.28849271 |
| 142 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.26407317 |
| 143 | keratan sulfate catabolic process (GO:0042340) | 2.25798923 |
| 144 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.25280576 |
| 145 | adhesion of symbiont to host cell (GO:0044650) | 2.24893728 |
| 146 | virion attachment to host cell (GO:0019062) | 2.24893728 |
| 147 | blood vessel maturation (GO:0001955) | 2.18467201 |
| 148 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.18421526 |
| 149 | response to epinephrine (GO:0071871) | 2.17610154 |
| 150 | endodermal cell differentiation (GO:0035987) | 2.16051186 |
| 151 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.15476797 |
| 152 | metanephric tubule development (GO:0072170) | 2.14998919 |
| 153 | metanephric nephron tubule development (GO:0072234) | 2.14998919 |
| 154 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.14733426 |
| 155 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.14439455 |
| 156 | negative regulation of catenin import into nucleus (GO:0035414) | 2.14205366 |
| 157 | peripheral nervous system axon ensheathment (GO:0032292) | 2.14020600 |
| 158 | myelination in peripheral nervous system (GO:0022011) | 2.14020600 |
| 159 | type B pancreatic cell proliferation (GO:0044342) | 2.13518812 |
| 160 | protein targeting to plasma membrane (GO:0072661) | 2.13514553 |
| 161 | regulation of extracellular matrix disassembly (GO:0010715) | 2.13012006 |
| 162 | metanephric epithelium development (GO:0072207) | 2.11614418 |
| 163 | cell proliferation involved in metanephros development (GO:0072203) | 2.09813188 |
| 164 | ethanol metabolic process (GO:0006067) | 2.07638938 |
| 165 | glycerolipid catabolic process (GO:0046503) | 2.06339973 |
| 166 | epithelial cell-cell adhesion (GO:0090136) | 2.05833761 |
| 167 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.05635191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.62341120 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.59687640 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.24312735 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.74698894 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60588796 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.35245493 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.25576669 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.24022042 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.05314725 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.93172861 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.82863866 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.22129359 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.19357258 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.15245990 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11115513 |
| 16 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.04919091 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04864232 |
| 18 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.98790832 |
| 19 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.98047988 |
| 20 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.98047988 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93069552 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91348203 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83562149 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.78273580 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.74366778 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.74038449 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71806400 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69984534 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67955055 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61250397 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.55642776 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55452691 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55452691 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50976251 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50910549 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50797769 |
| 37 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.49895958 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48921130 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47285351 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.45814160 |
| 41 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45595834 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44804814 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.40789153 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40479998 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40226145 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.39845427 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39409922 |
| 48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37619909 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35404108 |
| 50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33892232 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33673668 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33279458 |
| 53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33224802 |
| 54 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30953170 |
| 55 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.30666543 |
| 56 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28612733 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27912035 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27469069 |
| 59 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.27442823 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25590314 |
| 61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24906495 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23885265 |
| 63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23631263 |
| 64 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21109569 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20517520 |
| 66 | CJUN_26792858_Chip-Seq_BT549_Human | 1.20243066 |
| 67 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.19013185 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18425928 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17169435 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17089881 |
| 71 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.16665501 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16135042 |
| 73 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.15890557 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15798137 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13541108 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.12566919 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11908953 |
| 78 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11714808 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11431626 |
| 80 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11340083 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11005844 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10802343 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09132926 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08874878 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08328536 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08153077 |
| 87 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.08121465 |
| 88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06729364 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05939314 |
| 90 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.05828841 |
| 91 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05146005 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03493227 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03449929 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01820316 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00864557 |
| 96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00016507 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96910440 |
| 98 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.95408301 |
| 99 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94932077 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94497376 |
| 101 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94135089 |
| 102 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.93373105 |
| 103 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92420711 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91795618 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91390765 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91149750 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90851979 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90841435 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89160704 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88052914 |
| 111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87782960 |
| 112 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87751185 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86942577 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86942577 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86903930 |
| 116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86735537 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85595891 |
| 118 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.85453759 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85231480 |
| 120 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85110942 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84372285 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84013648 |
| 123 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.83904983 |
| 124 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83202000 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81207727 |
| 126 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80167919 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79851121 |
| 128 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79787016 |
| 129 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.79711355 |
| 130 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79318001 |
| 131 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.79239500 |
| 132 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78692215 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78657566 |
| 134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78525278 |
| 135 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.77631473 |
| 136 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.77562210 |
| 137 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77410886 |
| 138 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.77046548 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77021620 |
| 140 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76539568 |
| 141 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.76074666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.80936283 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.45834631 |
| 3 | MP0010368_abnormal_lymphatic_system | 3.26804922 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.05771173 |
| 5 | MP0005670_abnormal_white_adipose | 2.95794013 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.94606304 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.82153957 |
| 8 | MP0000751_myopathy | 2.81211564 |
| 9 | MP0005360_urolithiasis | 2.79840503 |
| 10 | MP0005365_abnormal_bile_salt | 2.56924899 |
| 11 | MP0004272_abnormal_basement_membrane | 2.55534902 |
| 12 | MP0004130_abnormal_muscle_cell | 2.50826048 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.40891737 |
| 14 | MP0005275_abnormal_skin_tensile | 2.33957006 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 2.24866353 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.16605663 |
| 17 | MP0005666_abnormal_adipose_tissue | 2.15689781 |
| 18 | MP0005330_cardiomyopathy | 2.12658720 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 1.98770971 |
| 20 | MP0005409_darkened_coat_color | 1.96618664 |
| 21 | MP0003252_abnormal_bile_duct | 1.93486168 |
| 22 | MP0004215_abnormal_myocardial_fiber | 1.92122761 |
| 23 | MP0006138_congestive_heart_failure | 1.90152838 |
| 24 | MP0003279_aneurysm | 1.89780978 |
| 25 | MP0003646_muscle_fatigue | 1.87942947 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.85200628 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.84244479 |
| 28 | MP0008775_abnormal_heart_ventricle | 1.82710851 |
| 29 | MP0004087_abnormal_muscle_fiber | 1.76649245 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.76339570 |
| 31 | MP0005503_abnormal_tendon_morphology | 1.69480543 |
| 32 | MP0000749_muscle_degeneration | 1.68629544 |
| 33 | MP0005375_adipose_tissue_phenotype | 1.67141037 |
| 34 | MP0005385_cardiovascular_system_phenoty | 1.66782440 |
| 35 | MP0001544_abnormal_cardiovascular_syste | 1.66782440 |
| 36 | MP0001958_emphysema | 1.65675594 |
| 37 | MP0010630_abnormal_cardiac_muscle | 1.62948804 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.60048248 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.59726443 |
| 40 | MP0003828_pulmonary_edema | 1.59257939 |
| 41 | MP0005332_abnormal_amino_acid | 1.56288164 |
| 42 | MP0002933_joint_inflammation | 1.55397722 |
| 43 | MP0002972_abnormal_cardiac_muscle | 1.52724084 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.50258304 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.44880483 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.44309792 |
| 47 | MP0005620_abnormal_muscle_contractility | 1.42106176 |
| 48 | MP0002269_muscular_atrophy | 1.36821744 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.34258768 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.32143062 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.32105553 |
| 52 | MP0004858_abnormal_nervous_system | 1.31122355 |
| 53 | MP0002249_abnormal_larynx_morphology | 1.27879685 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.23498823 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.22946980 |
| 56 | MP0002971_abnormal_brown_adipose | 1.21159534 |
| 57 | MP0001849_ear_inflammation | 1.20236851 |
| 58 | MP0000767_abnormal_smooth_muscle | 1.17361422 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.15325487 |
| 60 | MP0002108_abnormal_muscle_morphology | 1.14558253 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.14262991 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 1.14110906 |
| 63 | MP0009840_abnormal_foam_cell | 1.13890457 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.11777762 |
| 65 | MP0003879_abnormal_hair_cell | 1.10466392 |
| 66 | MP0000759_abnormal_skeletal_muscle | 1.10089428 |
| 67 | MP0003690_abnormal_glial_cell | 1.09433356 |
| 68 | MP0002106_abnormal_muscle_physiology | 1.08990064 |
| 69 | MP0004484_altered_response_of | 1.08716678 |
| 70 | MP0003137_abnormal_impulse_conducting | 1.07867476 |
| 71 | MP0005083_abnormal_biliary_tract | 1.07227564 |
| 72 | MP0000343_altered_response_to | 1.06603762 |
| 73 | MP0000609_abnormal_liver_physiology | 1.06226883 |
| 74 | MP0003195_calcinosis | 1.05312079 |
| 75 | MP0000747_muscle_weakness | 1.04137046 |
| 76 | MP0002128_abnormal_blood_circulation | 1.03730909 |
| 77 | MP0005171_absent_coat_pigmentation | 1.02339874 |
| 78 | MP0005369_muscle_phenotype | 1.01662979 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 0.99804488 |
| 80 | MP0004233_abnormal_muscle_weight | 0.99358574 |
| 81 | MP0005165_increased_susceptibility_to | 0.98875851 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.97232259 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.96795958 |
| 84 | MP0004510_myositis | 0.96528467 |
| 85 | MP0001661_extended_life_span | 0.95727620 |
| 86 | MP0002060_abnormal_skin_morphology | 0.93391882 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.92142211 |
| 88 | MP0004085_abnormal_heartbeat | 0.92068006 |
| 89 | MP0001756_abnormal_urination | 0.89109859 |
| 90 | MP0009115_abnormal_fat_cell | 0.88285665 |
| 91 | MP0005595_abnormal_vascular_smooth | 0.87650720 |
| 92 | MP0006054_spinal_hemorrhage | 0.86353195 |
| 93 | MP0001542_abnormal_bone_strength | 0.85999462 |
| 94 | MP0005023_abnormal_wound_healing | 0.85998034 |
| 95 | MP0001666_abnormal_nutrient_absorption | 0.85608817 |
| 96 | MP0000266_abnormal_heart_morphology | 0.84717115 |
| 97 | MP0001502_abnormal_circadian_rhythm | 0.84493304 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.83185512 |
| 99 | MP0005334_abnormal_fat_pad | 0.82194322 |
| 100 | MP0003950_abnormal_plasma_membrane | 0.82067016 |
| 101 | MP0003045_fibrosis | 0.80393324 |
| 102 | MP0002168_other_aberrant_phenotype | 0.79897913 |
| 103 | MP0010030_abnormal_orbit_morphology | 0.79415442 |
| 104 | MP0003329_amyloid_beta_deposits | 0.77816285 |
| 105 | MP0002970_abnormal_white_adipose | 0.77740711 |
| 106 | MP0002127_abnormal_cardiovascular_syste | 0.77556314 |
| 107 | MP0005164_abnormal_response_to | 0.76810565 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.76281833 |
| 109 | MP0001614_abnormal_blood_vessel | 0.75876403 |
| 110 | MP0002133_abnormal_respiratory_system | 0.75692122 |
| 111 | MP0005388_respiratory_system_phenotype | 0.75692122 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.75396586 |
| 113 | MP0003091_abnormal_cell_migration | 0.75320172 |
| 114 | MP0000249_abnormal_blood_vessel | 0.73763083 |
| 115 | MP0005535_abnormal_body_temperature | 0.72977991 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72687117 |
| 117 | MP0000163_abnormal_cartilage_morphology | 0.72538616 |
| 118 | MP0003724_increased_susceptibility_to | 0.72407903 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.72187836 |
| 120 | MP0003283_abnormal_digestive_organ | 0.71449306 |
| 121 | MP0000733_abnormal_muscle_development | 0.71367148 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.71292679 |
| 123 | MP0003868_abnormal_feces_composition | 0.71215693 |
| 124 | MP0005508_abnormal_skeleton_morphology | 0.70419838 |
| 125 | MP0002896_abnormal_bone_mineralization | 0.70206380 |
| 126 | MP0006036_abnormal_mitochondrial_physio | 0.70004349 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.69634972 |
| 128 | MP0004019_abnormal_vitamin_homeostasis | 0.69462827 |
| 129 | MP0004145_abnormal_muscle_electrophysio | 0.69300913 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.67160378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased connective tissue (HP:0009025) | 4.12202500 |
| 2 | Muscle fiber splitting (HP:0003555) | 3.94084817 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.89615298 |
| 4 | Broad metatarsal (HP:0001783) | 3.87235858 |
| 5 | Sudden death (HP:0001699) | 3.75486615 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 3.72415794 |
| 7 | Protrusio acetabuli (HP:0003179) | 3.55901786 |
| 8 | Ventricular tachycardia (HP:0004756) | 3.52917949 |
| 9 | Obstructive sleep apnea (HP:0002870) | 3.46229072 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 3.40558169 |
| 11 | Cervical subluxation (HP:0003308) | 3.37148038 |
| 12 | Polycythemia (HP:0001901) | 3.35466744 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.31533079 |
| 14 | Myoglobinuria (HP:0002913) | 3.29649338 |
| 15 | Ketoacidosis (HP:0001993) | 3.26644550 |
| 16 | Mesangial abnormality (HP:0001966) | 3.18859634 |
| 17 | Ketosis (HP:0001946) | 3.16589419 |
| 18 | Ankle contracture (HP:0006466) | 3.02801639 |
| 19 | Lipoatrophy (HP:0100578) | 3.02607956 |
| 20 | Cerebral aneurysm (HP:0004944) | 3.02359384 |
| 21 | Vascular tortuosity (HP:0004948) | 3.01125095 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.97902562 |
| 23 | Hyperglycinuria (HP:0003108) | 2.97448192 |
| 24 | Premature rupture of membranes (HP:0001788) | 2.95511592 |
| 25 | Xanthomatosis (HP:0000991) | 2.95088602 |
| 26 | Round ear (HP:0100830) | 2.86994027 |
| 27 | Exercise-induced myalgia (HP:0003738) | 2.86981527 |
| 28 | Lymphangioma (HP:0100764) | 2.86324076 |
| 29 | Type 1 muscle fiber predominance (HP:0003803) | 2.86295643 |
| 30 | Wormian bones (HP:0002645) | 2.80319492 |
| 31 | Hyperammonemia (HP:0001987) | 2.78371020 |
| 32 | Atrial fibrillation (HP:0005110) | 2.78237327 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 2.75742067 |
| 34 | Joint stiffness (HP:0001387) | 2.73587043 |
| 35 | Bladder diverticulum (HP:0000015) | 2.71939169 |
| 36 | Difficulty running (HP:0009046) | 2.70303606 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 2.70217645 |
| 38 | Complement deficiency (HP:0004431) | 2.68634747 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 2.67028785 |
| 40 | Distal lower limb muscle weakness (HP:0009053) | 2.64510708 |
| 41 | Wrist flexion contracture (HP:0001239) | 2.62498122 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 2.59411003 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.58333296 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.58333296 |
| 45 | Arterial tortuosity (HP:0005116) | 2.56836548 |
| 46 | Thin bony cortex (HP:0002753) | 2.55738849 |
| 47 | Primary atrial arrhythmia (HP:0001692) | 2.52803101 |
| 48 | Aortic regurgitation (HP:0001659) | 2.51665266 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.50907117 |
| 50 | Vertebral compression fractures (HP:0002953) | 2.50579720 |
| 51 | Aneurysm (HP:0002617) | 2.49512494 |
| 52 | Exercise-induced muscle cramps (HP:0003710) | 2.49113851 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.47894496 |
| 54 | Hyperlipoproteinemia (HP:0010980) | 2.46876002 |
| 55 | Spinal rigidity (HP:0003306) | 2.46025450 |
| 56 | Atrioventricular block (HP:0001678) | 2.45739699 |
| 57 | Soft skin (HP:0000977) | 2.45187331 |
| 58 | Biconcave vertebral bodies (HP:0004586) | 2.45063773 |
| 59 | Supraventricular arrhythmia (HP:0005115) | 2.43046299 |
| 60 | Aortic aneurysm (HP:0004942) | 2.41260674 |
| 61 | Calf muscle hypertrophy (HP:0008981) | 2.41041435 |
| 62 | Dilated cardiomyopathy (HP:0001644) | 2.40710722 |
| 63 | Mitral regurgitation (HP:0001653) | 2.39089850 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39056446 |
| 65 | Abnormality of the calf musculature (HP:0001430) | 2.38610906 |
| 66 | Supraventricular tachycardia (HP:0004755) | 2.36850884 |
| 67 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.35361278 |
| 68 | Atrophic scars (HP:0001075) | 2.32971284 |
| 69 | Fragile skin (HP:0001030) | 2.32245533 |
| 70 | Dilatation of the ascending aorta (HP:0005111) | 2.30404223 |
| 71 | Rhabdomyolysis (HP:0003201) | 2.30312764 |
| 72 | J-shaped sella turcica (HP:0002680) | 2.29450995 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27918538 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.27918538 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.27202408 |
| 76 | Skin nodule (HP:0200036) | 2.25833634 |
| 77 | Broad face (HP:0000283) | 2.25548128 |
| 78 | Focal segmental glomerulosclerosis (HP:0000097) | 2.23893258 |
| 79 | Aortic valve stenosis (HP:0001650) | 2.23506783 |
| 80 | Esophageal varix (HP:0002040) | 2.22933577 |
| 81 | Myocardial infarction (HP:0001658) | 2.22706245 |
| 82 | Nuclear cataract (HP:0100018) | 2.21970566 |
| 83 | Blue sclerae (HP:0000592) | 2.19675438 |
| 84 | Difficulty climbing stairs (HP:0003551) | 2.19528380 |
| 85 | Shallow orbits (HP:0000586) | 2.19356880 |
| 86 | Palpitations (HP:0001962) | 2.19341119 |
| 87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18930854 |
| 88 | Aortic dissection (HP:0002647) | 2.18400729 |
| 89 | Overgrowth (HP:0001548) | 2.18056632 |
| 90 | Hypoplastic ischia (HP:0003175) | 2.15985694 |
| 91 | Mitral stenosis (HP:0001718) | 2.15958145 |
| 92 | Stridor (HP:0010307) | 2.14099245 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.12066729 |
| 94 | Acanthosis nigricans (HP:0000956) | 2.10714149 |
| 95 | Ectopia lentis (HP:0001083) | 2.08823153 |
| 96 | Abnormal atrioventricular conduction (HP:0005150) | 2.07932807 |
| 97 | Heart block (HP:0012722) | 2.07072606 |
| 98 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.06463133 |
| 99 | EMG: myopathic abnormalities (HP:0003458) | 2.05980667 |
| 100 | Syncope (HP:0001279) | 2.05642352 |
| 101 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.04792001 |
| 102 | Visceral angiomatosis (HP:0100761) | 2.03828747 |
| 103 | Hyperglycinemia (HP:0002154) | 2.03426374 |
| 104 | Hypoplasia of the iris (HP:0007676) | 2.02899874 |
| 105 | Abnormality of the ischium (HP:0003174) | 2.02081366 |
| 106 | Nephritis (HP:0000123) | 2.01865311 |
| 107 | Bundle branch block (HP:0011710) | 2.01249015 |
| 108 | Joint hemorrhage (HP:0005261) | 2.00675271 |
| 109 | Hypolipoproteinemia (HP:0010981) | 1.99898054 |
| 110 | Pulmonary artery stenosis (HP:0004415) | 1.99806245 |
| 111 | Subaortic stenosis (HP:0001682) | 1.99783512 |
| 112 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.99783512 |
| 113 | Turricephaly (HP:0000262) | 1.99577286 |
| 114 | Bronchomalacia (HP:0002780) | 1.96613295 |
| 115 | Slender build (HP:0001533) | 1.96141433 |
| 116 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.95219360 |
| 117 | Gout (HP:0001997) | 1.95209741 |
| 118 | Distal upper limb amyotrophy (HP:0007149) | 1.94697304 |
| 119 | Upper limb amyotrophy (HP:0009129) | 1.94697304 |
| 120 | Joint laxity (HP:0001388) | 1.94126343 |
| 121 | Hematochezia (HP:0002573) | 1.93825843 |
| 122 | Myotonia (HP:0002486) | 1.93079883 |
| 123 | Neck muscle weakness (HP:0000467) | 1.92886696 |
| 124 | Lower limb amyotrophy (HP:0007210) | 1.92138455 |
| 125 | Glomerulonephritis (HP:0000099) | 1.92045125 |
| 126 | Epidermoid cyst (HP:0200040) | 1.90969062 |
| 127 | Glomerulosclerosis (HP:0000096) | 1.90647970 |
| 128 | Abnormality of complement system (HP:0005339) | 1.90578257 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 1.90395772 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.89415652 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89415652 |
| 132 | Generalized aminoaciduria (HP:0002909) | 1.89232180 |
| 133 | Ventricular arrhythmia (HP:0004308) | 1.89121560 |
| 134 | Hydroxyprolinuria (HP:0003080) | 1.88099371 |
| 135 | Abnormality of proline metabolism (HP:0010907) | 1.88099371 |
| 136 | Hyperglycemia (HP:0003074) | 1.87425728 |
| 137 | Hemangiomatosis (HP:0007461) | 1.87244820 |
| 138 | Oligomenorrhea (HP:0000876) | 1.87163719 |
| 139 | Neonatal short-limb short stature (HP:0008921) | 1.86188736 |
| 140 | Follicular hyperkeratosis (HP:0007502) | 1.86062625 |
| 141 | Generalized amyotrophy (HP:0003700) | 1.85384051 |
| 142 | Venous abnormality (HP:0002624) | 1.85236521 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.84698854 |
| 144 | Mitral valve prolapse (HP:0001634) | 1.83340265 |
| 145 | Hip contracture (HP:0003273) | 1.83190528 |
| 146 | Infantile muscular hypotonia (HP:0008947) | 1.82177933 |
| 147 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80612956 |
| 148 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80612956 |
| 149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80612956 |
| 150 | Striae distensae (HP:0001065) | 1.80270149 |
| 151 | Long toe (HP:0010511) | 1.79573303 |
| 152 | Prolonged QT interval (HP:0001657) | 1.79392252 |
| 153 | Ulnar bowing (HP:0003031) | 1.78875039 |
| 154 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.78725300 |
| 155 | Axonal loss (HP:0003447) | 1.78404272 |
| 156 | Hemorrhage of the eye (HP:0011885) | 1.78231397 |
| 157 | Limited hip movement (HP:0008800) | 1.76735385 |
| 158 | Bradycardia (HP:0001662) | 1.75956697 |
| 159 | Hyperextensible skin (HP:0000974) | 1.75533016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.14468299 |
| 2 | TRIB3 | 4.11206771 |
| 3 | TTN | 3.58379240 |
| 4 | BCKDK | 3.07273997 |
| 5 | ERN1 | 3.05491864 |
| 6 | SIK1 | 2.66791438 |
| 7 | PDGFRA | 2.41904263 |
| 8 | TGFBR2 | 2.41575442 |
| 9 | PKN2 | 2.37798195 |
| 10 | KDR | 2.35821654 |
| 11 | MYLK | 2.35740570 |
| 12 | WNK4 | 2.21215477 |
| 13 | DDR2 | 2.11108952 |
| 14 | RIPK1 | 2.10972289 |
| 15 | EPHB2 | 1.89622049 |
| 16 | LATS1 | 1.83076471 |
| 17 | FGFR4 | 1.78094990 |
| 18 | LMTK2 | 1.72282572 |
| 19 | CAMK1D | 1.68754314 |
| 20 | EEF2K | 1.65116771 |
| 21 | PHKG2 | 1.60232572 |
| 22 | PHKG1 | 1.60232572 |
| 23 | PDK3 | 1.56418928 |
| 24 | PDK4 | 1.56418928 |
| 25 | TESK1 | 1.54737020 |
| 26 | DMPK | 1.54725538 |
| 27 | NTRK1 | 1.51167170 |
| 28 | MARK2 | 1.42142111 |
| 29 | ICK | 1.39142339 |
| 30 | INSRR | 1.36919710 |
| 31 | EPHB1 | 1.36621567 |
| 32 | PINK1 | 1.33225951 |
| 33 | PTK6 | 1.27066307 |
| 34 | MAP2K3 | 1.24399618 |
| 35 | PDK2 | 1.23480459 |
| 36 | CAMK1G | 1.22953318 |
| 37 | RPS6KA2 | 1.14625797 |
| 38 | LATS2 | 1.13346510 |
| 39 | NTRK3 | 1.11322681 |
| 40 | MAPK15 | 1.10042622 |
| 41 | MAPK7 | 1.09354682 |
| 42 | OBSCN | 1.08866882 |
| 43 | EPHA2 | 1.08795861 |
| 44 | TGFBR1 | 1.08563301 |
| 45 | PRKD1 | 1.04367228 |
| 46 | PIK3CA | 1.02221583 |
| 47 | AKT3 | 1.01818250 |
| 48 | EPHA3 | 1.00476256 |
| 49 | FER | 0.99500532 |
| 50 | PRKAA2 | 0.98403845 |
| 51 | PRPF4B | 0.94089773 |
| 52 | MET | 0.93088610 |
| 53 | CAMK1 | 0.93066506 |
| 54 | MAP3K3 | 0.92896573 |
| 55 | MUSK | 0.91432758 |
| 56 | MAP3K7 | 0.90511183 |
| 57 | STK38L | 0.88079627 |
| 58 | BMX | 0.87816921 |
| 59 | FGFR2 | 0.86404213 |
| 60 | MAP3K6 | 0.85054679 |
| 61 | PRKD2 | 0.84537681 |
| 62 | STK39 | 0.82565655 |
| 63 | MARK1 | 0.81148909 |
| 64 | PDGFRB | 0.80386539 |
| 65 | PAK3 | 0.79569559 |
| 66 | PTK2 | 0.79244001 |
| 67 | FLT3 | 0.78931606 |
| 68 | MAP2K6 | 0.78837289 |
| 69 | PTK2B | 0.78377751 |
| 70 | MTOR | 0.78142118 |
| 71 | MAPK4 | 0.73677812 |
| 72 | TRPM7 | 0.72390352 |
| 73 | MAP3K13 | 0.71956122 |
| 74 | MST1R | 0.71873836 |
| 75 | LRRK2 | 0.70847815 |
| 76 | PRKAA1 | 0.69729867 |
| 77 | ROCK1 | 0.68895785 |
| 78 | PAK2 | 0.68705600 |
| 79 | ILK | 0.68553074 |
| 80 | PRKD3 | 0.68537874 |
| 81 | PAK4 | 0.67059479 |
| 82 | NEK9 | 0.66809995 |
| 83 | PRKCH | 0.66227829 |
| 84 | JAK1 | 0.64577277 |
| 85 | MAPK12 | 0.64161207 |
| 86 | GSK3A | 0.63489517 |
| 87 | CSK | 0.62523257 |
| 88 | CDC42BPA | 0.62019671 |
| 89 | FGFR3 | 0.61468811 |
| 90 | PAK6 | 0.60022668 |
| 91 | HIPK2 | 0.59503830 |
| 92 | GRK5 | 0.59353098 |
| 93 | RET | 0.56700577 |
| 94 | CAMK2G | 0.56566305 |
| 95 | TNK2 | 0.56515486 |
| 96 | MAP3K11 | 0.55277006 |
| 97 | MAPK11 | 0.54997892 |
| 98 | LIMK1 | 0.54914748 |
| 99 | MAP2K1 | 0.52377128 |
| 100 | KIT | 0.52250489 |
| 101 | ERBB2 | 0.52013939 |
| 102 | MAPKAPK3 | 0.51786416 |
| 103 | DAPK2 | 0.51076766 |
| 104 | ROCK2 | 0.51075440 |
| 105 | SGK223 | 0.49585305 |
| 106 | SGK494 | 0.49585305 |
| 107 | DAPK3 | 0.49354779 |
| 108 | PDPK1 | 0.48731492 |
| 109 | ZAP70 | 0.48092418 |
| 110 | PRKG2 | 0.47862270 |
| 111 | CAMK2B | 0.47576097 |
| 112 | FRK | 0.46215195 |
| 113 | CAMK4 | 0.45435177 |
| 114 | FGFR1 | 0.44331999 |
| 115 | MAP3K1 | 0.42651140 |
| 116 | JAK2 | 0.42356765 |
| 117 | CAMK2D | 0.41915887 |
| 118 | STK38 | 0.41616001 |
| 119 | DYRK1B | 0.41049072 |
| 120 | NEK1 | 0.40560903 |
| 121 | CDK6 | 0.38866913 |
| 122 | OXSR1 | 0.38850362 |
| 123 | WNK1 | 0.36663354 |
| 124 | RPS6KL1 | 0.36386708 |
| 125 | RPS6KC1 | 0.36386708 |
| 126 | MAP3K10 | 0.35338677 |
| 127 | RPS6KA6 | 0.34431350 |
| 128 | STK3 | 0.33875239 |
| 129 | TYRO3 | 0.33639467 |
| 130 | ABL2 | 0.33266943 |
| 131 | SGK3 | 0.32871821 |
| 132 | PIK3CG | 0.32507976 |
| 133 | PRKACG | 0.31831216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.18805449 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.07928783 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.98430037 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.96825898 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.94653909 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.80273124 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.72530447 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.50119709 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36206452 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.32284533 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24487300 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.21065650 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.19120412 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.93399262 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86227005 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78896438 |
| 17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.72037595 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69948580 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68636425 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61500277 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57231587 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53342826 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52573990 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.51907934 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.51210211 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.45787253 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43183472 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.39237804 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35369950 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.28987765 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27323750 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.24507302 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22390800 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19051893 |
| 35 | Focal adhesion_Homo sapiens_hsa04510 | 1.17035462 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.15219223 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14715807 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14541833 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13160919 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12491481 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12391084 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11962537 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11884939 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.10953065 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 1.09887038 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05028658 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02395201 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02173019 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00136377 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97229635 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96215031 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96182548 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94204000 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90482825 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89886506 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.89465686 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88870742 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88011700 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.87872813 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87717419 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85652847 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84482846 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83641267 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82798131 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81515630 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79855538 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.76769033 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76462857 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75357070 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.74644745 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73678918 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.73591581 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73408825 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73026675 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.72400078 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72294627 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72060040 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71544074 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70589687 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 0.70456532 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69530729 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69318829 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67928693 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67630391 |
| 85 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66681914 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65617542 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65025889 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.63805467 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62516295 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59962129 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59230864 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.58007596 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57989896 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57584614 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57496382 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57224380 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56298227 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56238608 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.55622509 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.54759595 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54600714 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53127209 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52435743 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51480829 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50454767 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49801283 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49641929 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49158843 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48464676 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.46861147 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46769047 |
| 112 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46341129 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44600163 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43413086 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40017355 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.39354056 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38429073 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36828220 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34863257 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34725574 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.34197656 |
| 122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34000818 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32499412 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32485065 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31624574 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30845799 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30308563 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28088274 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27204281 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.26254932 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25151406 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.24932029 |
| 133 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23015749 |
| 134 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21901629 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21853383 |
| 136 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21218822 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20564219 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20126070 |

